RO5095932

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO5095932, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus [Phase 1]